Lung Disease
Ofev Assistance Programs & Grants in Utah
Assistance information last verified: August 2026
Yes — and this is one of the few medications on this site with an open charitable fund. TotalAssist's Pulmonary fibrosis fund was accepting applications on August 26, 2026, lists Ofev, and pays a $3,500 guaranteed award up to $7,000. Boehringer Ingelheim also runs a patient assistance program that lists Ofev, though its current terms could not be confirmed. Medicare's negotiated price for Ofev starts January 1, 2027. Financial assistance may be available through charitable foundations, manufacturer programs, Medicare's Extra Help program, or other assistance resources. Availability and eligibility change frequently — the information on this page was verified in August 2026.
Can I get help paying for Ofev?
Yes — and this is one of the few medications on this site with an open charitable fund. TotalAssist's Pulmonary fibrosis fund was accepting applications on August 26, 2026, lists Ofev, and pays a $3,500 guaranteed award up to $7,000. Boehringer Ingelheim also runs a patient assistance program that lists Ofev, though its current terms could not be confirmed. Medicare's negotiated price for Ofev starts January 1, 2027.
- TotalAssist Pulmonary fibrosis fund: OPEN on August 26, 2026, $3,500 guaranteed and $7,000 maximum, for people with Medicare, Medicaid or TRICARE and income at or below 500% of the federal poverty level adjusted for local cost of living. "Ofev (Nintedanib Esylate)" is on its approved-medication list.
- Boehringer Cares Patient Assistance Program: the foundation's therapy list includes Ofev Capsules, and it supplies medicines free to patients who meet its criteria. Boehringer Ingelheim's website refused every automated request on the checked date, so call 1-800-556-8317 to confirm the income limit and Medicare rules.
- Ofev savings card: commercially insured patients only — Boehringer Ingelheim's terms exclude prescriptions reimbursable by Medicare, Medicaid, Medigap, VA, DoD or TRICARE.
- HealthWell: both applicable funds — Pulmonary Fibrosis and Systemic Sclerosis with ILD, each with a $9,000 maximum award — list Ofev, and both were closed to new patients. Set alerts.
- Medicare: a negotiated maximum fair price of $6,350.00 per 30-day equivalent supply takes effect January 1, 2027; Part D costs are capped at $2,100 in 2026; generic nintedanib is now labelled by eleven other manufacturers.
1 of the 6 programs we checked for Ofev was accepting applications when verified in August 2026.
About Ofev (nintedanib)
Ofev is a twice-daily capsule for scarring lung diseases. Nintedanib blocks several signalling enzymes involved in fibrosis, which slows the rate at which lung function declines. It is not an inhaler and does not open the airways — it is a different kind of medicine for a different kind of lung disease from COPD or asthma, and that distinction runs through every assistance program on this page.
Approved uses
- Treatment of idiopathic pulmonary fibrosis (IPF) in adults
- Treatment of chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype in adults
- Slowing the rate of decline in pulmonary function in adults with systemic sclerosis-associated interstitial lung disease (SSc-ILD)
Manufacturer: Boehringer Ingelheim
Why Ofev can be expensive on Medicare
Ofev is a specialty capsule taken twice a day indefinitely, and Medicare's own negotiation puts a number on the scale: CMS set a maximum fair price of $6,350.00 for a 30-day equivalent supply, effective January 1, 2027 — the negotiated price, which means the price before negotiation was higher still. On a Part D specialty tier the coinsurance on a drug at that level reaches the annual out-of-pocket cap quickly, usually in the first months of the year. The manufacturer savings card excludes Medicare, so a Part D beneficiary carries plan cost-sharing until the cap. The one thing that has changed the arithmetic recently is that generic nintedanib is now on the market — eleven capsule labels besides Boehringer Ingelheim's own.
Medicare coverage context
Ofev is a capsule you take yourself, so Medicare covers it under Part D or a Medicare Advantage drug plan, generally on a specialty tier with prior authorization. It is one of the 15 drugs CMS selected for the second cycle of Medicare drug price negotiation: the maximum fair price for Ofev is $6,350.00 per 30-day equivalent supply, and it takes effect on January 1, 2027 for people whose Part D plans cover it. Until then, and after, the Part D out-of-pocket cap applies — $2,100 in 2026 — and Extra Help lowers cost-sharing for people with limited income and resources. A negotiated price is not a cash price: it changes what plans and enrollees pay, not what a pharmacy charges someone paying out of pocket.
Check typical Part D coverage · Estimate your drug costs · Compare Part D plans in Vernal
Ofev assistance options at a glance
Every program we checked, what kind of help it is, whether people with Medicare can use it, and its status when we verified it. A medication being listed by a program is not the same as the program accepting applications.
About the income limits below: Income limits can differ between assistance programs even when both describe their eligibility as the same percentage of the federal poverty level. The dollar limits shown here come from each program's own published income table, and each program decides which year's poverty guidelines that table is built from and when it takes effect. Treat the figures as belonging to the program they are listed under — they are not interchangeable, and only the program can tell you which table it is applying to your application today.
| Program | Type of help | People with Medicare | Status (August 2026) |
|---|---|---|---|
| TotalAssist — Pulmonary fibrosis (PF) fund | Charitable grant | may apply | Accepting applications |
| Boehringer Cares Patient Assistance Program | Manufacturer patient assistance | not stated | Check current availability |
| Ofev savings card | Commercial copay / savings card | not eligible | Check current availability |
| Manufacturer cash price — none found for brand Ofev | Manufacturer self-pay pricing | not stated | No program found |
| HealthWell Foundation — Pulmonary Fibrosis and Systemic Sclerosis with ILD funds | Charitable grant | may apply | Closed to new applicants |
| Good Days — no applicable fund | Charitable grant | not stated | No program found |
| Medicare Extra Help (Part D Low-Income Subsidy) | Government program | may apply | Accepting applications |
Manufacturer programs from Boehringer Ingelheim
A patient assistance program (free or low-cost drug by income) is not the same as a copay card (a commercial discount that usually excludes Medicare). Both are listed so you can see which one applies to you.
Manufacturer patient assistance
Boehringer Cares Patient Assistance Program
Boehringer Ingelheim Cares Foundation
Status: Listed, but current terms could not be confirmed on August 26, 2026. Boehringer Ingelheim's own program pages returned an automated block to every request, so the income limit, the Medicare rules and the current medicine list were not read at the source. What we could confirm: the foundation's own program description, published through PhRMA's Partnership for Prescription Assistance, lists "Ofev® Capsules" among the therapies offered; and an independent program directory updated April 27, 2026 records the phone, the fax and a Medicare Part D note.
The Boehringer Ingelheim Cares Foundation supplies Boehringer Ingelheim medicines free of charge to U.S. patients who meet its criteria, with no charge to apply, to refill, to call, or to have the medicine shipped. Ofev is on the foundation's therapy list.
If you have Medicare: Boehringer Ingelheim's official statement of its Medicare rules could not be read on the checked date, so we are not stating one. The RxAssist directory entry (updated April 27, 2026) reports "Patients with Medicare Part D may be eligible, contact program for details" and lists the income limit as "Not Published". Ask on the call whether the program requires you to apply for Extra Help first, and whether it asks Medicare applicants to pursue charitable funds before enrolling — both are common conditions, and neither was confirmed for this program.
What it can cover: Boehringer Ingelheim medicines at no cost to approved patients, shipped free.
Who may qualify
- U.S. patient prescribed a Boehringer Ingelheim medicine on the program list — Ofev Capsules are listed
- Household income within the program's limit — the limit is not published, so it must be confirmed with the program
- Insurance status rules for Medicare Part D beneficiaries were not confirmed at the source; ask when you call
What the application asks for
- Financial documentation — a federal tax return or another form the program accepts
- Prescription information and your prescriber's licence details (NPI)
- Your insurance details, including your Medicare and Part D plan information
How to apply
Call the program on 1-800-556-8317, Monday–Friday 8:30am–6:00pm ET, and ask it to send the current application and income guidelines — the reliable route while the website is the part we could not read. Applications are completed by you together with your prescriber and returned to the foundation. There is no fee to apply.
Commercial copay / savings card
Ofev savings card
Boehringer Ingelheim
Status: Boehringer Ingelheim publishes savings-card terms for Ofev, but the only copy reachable on August 26, 2026 states "Benefits not to exceed Program expiration on 12/31/2024" — an expired document, and one headed "Ofev (nintedanib) tablets" although Ofev is supplied as capsules. No dollar amount or monthly maximum is published here for that reason. The government-insurance exclusion below is the part that is stable across versions.
A commercial copay card for people with private or employer prescription insurance that covers Ofev. It is not insurance, is not accepted at VA pharmacies, and cannot be combined with another coupon or discount card.
If you have Medicare: Boehringer Ingelheim's terms: the offer is "Only valid for commercially insured patients… whose insurance policy provides coverage for OFEV," and "not valid for patients without commercial coverage or patients whose prescriptions for OFEV are eligible to be reimbursed, in whole or in part, by any federal healthcare programs such as Medicaid, Medicare, Medigap, the Retiree Drug Subsidy Program, VA, DOD, TRICARE, or any state patient or pharmaceutical assistance program." A Medicare beneficiary cannot use it.
What it can cover: Part of the commercial copay for Ofev. Nothing toward Medicare cost-sharing.
Who may qualify
- Commercial prescription insurance that covers Ofev and does not reimburse the entire cost
- Not covered by Medicare, Medicaid, Medigap, TRICARE, VA, DoD or a state pharmaceutical assistance program
- Current dollar terms unconfirmed — ask Boehringer Ingelheim before you rely on a figure
How to apply
Commercially insured patients enrol through the Ofev product website or the program phone line. Medicare beneficiaries should apply to the TotalAssist Pulmonary fibrosis fund and to Boehringer Cares instead.
Manufacturer self-pay pricing
Manufacturer cash price — none found for brand Ofev
Boehringer Ingelheim
Status: We found no Boehringer Ingelheim self-pay or direct-purchase price for Ofev on August 26, 2026, and brand Ofev is not among the medicines listed on TrumpRx. A generic nintedanib esylate capsule is listed there, at prices the site sets by location — so no fixed figure is quoted here.
An honest negative for the brand. The cash comparison that does exist is the generic: eleven manufacturers besides Boehringer Ingelheim now hold a nintedanib capsule label, and TotalAssist says its funds cover generic or bioequivalent drugs for the diagnosis.
If you have Medicare: Not applicable — there is no manufacturer cash-pay programme for Ofev to have a Medicare rule. Note that the Medicare negotiated price is also not a cash price: it applies through Part D plans, not at the counter for someone paying out of pocket.
How to apply
Not applicable. Ask your prescriber and pharmacist about generic nintedanib, and ask your plan what it charges for it against the brand.
Charitable grants for Ofev
One fund was open, and it is the right one. TotalAssist's Pulmonary fibrosis fund was accepting applications on August 26, 2026, lists "Ofev (Nintedanib Esylate)", and pays a $3,500 guaranteed award up to $7,000 for people with Medicare, Medicaid or TRICARE and income at or below 500% of the federal poverty level adjusted for local cost of living. HealthWell's Pulmonary Fibrosis and Systemic Sclerosis with ILD funds also list Ofev, with a $9,000 maximum award each, and both were closed — worth alerts, because that is the largest grant in this registry. One thing to be careful about: the COPD and asthma funds are not your funds. They are separate funds with less money, they were closed, and they do not list Ofev. If a directory or a well-meaning helper points you at a COPD fund because Ofev is a lung medicine, that is the wrong door.
Charitable grant
TotalAssist — Pulmonary fibrosis (PF) fund
Patient Advocate Foundation · Pulmonary fibrosis (PF)
Status: Open and accepting applications on August 26, 2026, with an instant approval decision online. This is a different fund from the COPD and Asthma funds, which were closed and do not cover Ofev — apply to this one.
A copay and cost-sharing grant for people with pulmonary fibrosis. "Ofev (Nintedanib Esylate)" is named on the fund's approved-medication list, alongside Esbriet and pirfenidone, Jascayd, and the immunosuppressants used in fibrosing ILD. Patient Advocate Foundation states it covers the prescription medications for the diagnosis including generic or bioequivalent drugs — relevant now that generic nintedanib exists.
If you have Medicare: The fund requires government-insured coverage — Medicare, Medicaid or TRICARE — that covers your qualifying expenses. Medicare beneficiaries are exactly who it is for.
What it can cover: $3,500 guaranteed award and up to $7,000 maximum, usable for medication copays, coinsurance and deductibles, health-insurance premiums and other qualifying expenses. One grant per condition.
Who may qualify
- Confirmed pulmonary fibrosis diagnosis, in treatment, planning to begin treatment within 60 days, or treated in the past 6 months — active surveillance counts
- Government-insured coverage (Medicare, Medicaid or TRICARE) that covers your qualifying expenses
- Household income at or below 500% of the federal poverty level, adjusted for your regional cost-of-living index
- Confirmed diagnosis matching the fund, and in treatment (or starting within 60 days, or treated in the past 6 months)
- Legal U.S. resident receiving treatment in the U.S. or a U.S. territory
What the application asks for
- Contact information and Social Security number (or alien number)
- Annual household income (for pre-screening; proof of income due within 30 days of approval)
- Health insurance carrier, plan type, policy ID and group number; Medicare supplement or secondary insurance if you have one
- Copay or coinsurance amounts
- Your provider's name and contact information, diagnosis (exact date if within 6 months), prescribed medications and treatment plan
How to apply
You (the patient) apply online — it takes about 15 minutes and you learn immediately whether you are approved — or call 866-512-3861, Monday–Friday 8:30am–5:30pm ET. Patient Advocate Foundation verifies your diagnosis and treatment plan directly with your provider and verifies income automatically; you have 30 days after approval to provide proof of income.
Charitable grant
HealthWell Foundation — Pulmonary Fibrosis and Systemic Sclerosis with ILD funds
HealthWell Foundation · Pulmonary Fibrosis · Systemic Sclerosis with Interstitial Lung Disease
Status: Both funds were "temporarily closed to new patients due to lack of sufficient funding" on August 26, 2026. Ofev and nintedanib are on both covered-medication lists. Which fund applies to you depends on your diagnosis, not on your medication.
HealthWell runs two funds that cover Ofev, matched to the two diagnoses the label names — pulmonary fibrosis, and systemic sclerosis with interstitial lung disease. Both carry a $9,000 maximum award, the largest of any fund in this registry, and both were closed when we checked. HealthWell says replenished funds reopen "as quickly as possible" and offers alerts per fund.
If you have Medicare: Medicare qualifies as the insurance these funds require. Premium assistance through either fund is limited to a Medicare Part B premium; the copay assistance applies to the prescription itself.
What it can cover: When open: up to $9,000 per grant for prescription copays, or a Medicare Part B premium. Household income up to 500% of the federal poverty level on HealthWell's own table, adjusted for household size and cost of living.
Who may qualify
- Insurance that pays part of the cost of Ofev — Medicare qualifies; discount cards do not count as insurance
- Household income up to 500% of the federal poverty level (HealthWell's own table — do not carry another program's dollar figures across)
- A pulmonary fibrosis or systemic sclerosis with ILD diagnosis, verified by a physician, nurse practitioner or physician assistant
- Treatment in the United States
What the application asks for
- Some form of health insurance (Medicare qualifies) that covers part of the cost of the drug — discount cards do not count
- Social Security number (used to prevent duplicate applications)
- Diagnosis verified by a physician's, nurse practitioner's or physician assistant's signature
- Treatment in the United States
How to apply
When a fund is open, apply online or by phone; your provider verifies the diagnosis by signature. When a fund is closed, sign up for that fund's real-time alerts — HealthWell says replenished funds reopen "as quickly as possible."
Charitable grant
Good Days — no applicable fund
Good Days
Status: Good Days' published disease list on August 26, 2026 contained no pulmonary fibrosis, interstitial lung disease or systemic sclerosis fund. Its nearest lung entry, Pulmonary Arterial Hypertension, was closed and is a different diagnosis.
An honest negative, checked so you do not spend time on a third foundation that has no fund for you.
If you have Medicare: Good Days accepts Medicare beneficiaries for the diseases it covers, but it covers no diagnosis that applies to Ofev.
How to apply
Not applicable today. The diseases-covered page shows every fund and whether it is open.
How to apply for Ofev assistance
The written steps are complete on their own; the video above will walk through the same process when it is published.
-
Step 1 — Find the applicable assistance program
For Ofev on Medicare in August 2026 the order is clear, because one fund was actually open: TotalAssist first, then Boehringer Cares, with Extra Help alongside both.
- Pulmonary fibrosis diagnosis, Medicare (or Medicaid/TRICARE), income at or below 500% FPL → TotalAssist Pulmonary fibrosis fund, open when we checked.
- On Medicare with limited income → call Boehringer Cares on 1-800-556-8317 for the current application and income guidelines.
- Limited income and resources → Medicare Extra Help through Social Security; on a specialty tier this is the largest structural saving.
- Systemic sclerosis with ILD → set an alert on HealthWell's SSc-ILD fund as well as the Pulmonary Fibrosis one.
- Commercial insurance instead of Medicare → the Ofev savings card, which Medicare enrollees cannot use.
-
Step 2 — Check whether applications are currently open
Keep two kinds of uncertainty apart here. TotalAssist was verifiably open and HealthWell verifiably closed. The Boehringer Ingelheim programs are unverified — neither confirmed open nor closed.
- TotalAssist: the Pulmonary fibrosis fund page shows "Open" or "Closed" and the current award amounts. Fund balances change without notice.
- HealthWell: the Disease Funds page shows the status of both applicable funds; sign up for alerts on each.
- Boehringer Cares: the phone line is the reliable check while the website blocks automated access.
-
Step 3 — Check eligibility
Each program applies its own rules and its own income table. Never carry a dollar figure from one program to another — each builds its table from a poverty-guideline year of its own choosing.
- TotalAssist: government insurance that covers Ofev; income at or below 500% of the federal poverty level adjusted for your regional cost-of-living index; confirmed pulmonary fibrosis in treatment (or beginning within 60 days, or treated in the past 6 months, including active surveillance).
- HealthWell (when open): insurance that pays part of the cost — Medicare qualifies; income up to 500% FPL on HealthWell's table; diagnosis verified by your provider's signature.
- Boehringer Cares: income limit not published — ask. Medicare Part D patients may be eligible according to an April 2026 directory entry, but confirm by phone.
- Extra Help: income below about $23,940 a year for one person or $32,460 for a couple, and countable resources limited to $18,090 or $36,100 in 2026.
-
Step 4 — Gather your information
The TotalAssist application takes about 15 minutes with these to hand:
- Medicare card and your Part D or Medicare Advantage drug-plan card, with policy ID and group number.
- Your exact diagnosis — idiopathic pulmonary fibrosis, another chronic fibrosing ILD, or systemic sclerosis with ILD — and its date. The diagnosis, not the medication, decides which fund matches.
- Your prescriber's name and contact details, plus the NPI if you are also applying to Boehringer Cares.
- Household size and annual household income, with proof — TotalAssist gives you 30 days after approval to supply it; Boehringer Cares is reported to ask for a federal tax return.
- Your Ofev prescription details, including strength (100 mg or 150 mg capsules).
-
Step 5 — Complete the application
Who fills out what:
- TotalAssist: you (the patient) apply online in about 15 minutes, or by phone on 866-512-3861, Monday–Friday 8:30am–5:30pm ET. Patient Advocate Foundation verifies the diagnosis with your provider.
- Boehringer Cares: you and your prescriber complete the application together and return it to the foundation.
- HealthWell (when open): apply online or by phone; your provider verifies the diagnosis by signature.
- Extra Help: you (or someone helping you) apply free through Social Security — online, by phone on 1-800-772-1213, or at an office.
-
Step 6 — Submit and wait for a determination
What to expect:
- TotalAssist: you learn immediately online whether you are approved, and can use the grant right away; proof of income is due within 30 days.
- Boehringer Cares: ask about the decision timeline on the call — we could not confirm it from an official source, so we are not publishing a number.
- HealthWell (when open): approval creates a 12-month grant cycle with a pharmacy card.
- Extra Help: Social Security notifies you by mail; your Part D plan then applies the lower copays.
-
Step 7 — If the program is closed or you don't qualify
On a specialty-tier medication, the next steps are worth taking seriously rather than skimming:
- Ask your prescriber about generic nintedanib — eleven manufacturers besides Boehringer Ingelheim now hold a capsule label, and TotalAssist says its funds cover generic and bioequivalent drugs for the diagnosis.
- Sign up for HealthWell alerts on both the Pulmonary Fibrosis and the SSc-ILD fund; at a $9,000 maximum, these are the largest grants in this registry.
- Apply for Extra Help even if you assume you earn too much — on a specialty tier it is the difference between coinsurance and about $12.65 for a covered brand drug.
- From January 1, 2027, Medicare's negotiated maximum fair price of $6,350.00 per 30-day equivalent supply applies through Part D plans — factor that into a plan comparison during the fall enrollment period.
- Use the Medicare Prescription Payment Plan to spread this year's out-of-pocket costs across monthly payments; on a drug that hits the cap early, this smooths a very uneven year.
- Call Vernal Medicare — we will work through every route above with you, free.
What you'll need
Only items the programs above actually ask for. Gather these before you start.
- Medicare card and your Part D or Medicare Advantage drug-plan card — plan name, member ID and group number
- Prescription details — medication name, strength and dose; prescriber name, office phone and address
- Diagnosis and date of diagnosis — TotalAssist needs the exact date if diagnosed within the past 6 months
- Household size and annual household income — and proof — tax return, Social Security or pension statements, or pay stubs
- Your exact fibrosing lung diagnosis — IPF, another progressive fibrosing ILD, or SSc-ILD — the diagnosis decides which fund matches, not the medication
- A federal tax return or other income documentation — reported as the financial documentation Boehringer Cares asks for
- Your prescriber's NPI — the manufacturer application asks for the prescriber licence details
Could Medicare Extra Help reduce your Ofev costs?
Extra Help is not a grant for Ofev. It is a Medicare program that lowers what qualifying beneficiaries pay for their Part D premium, deductible and every covered prescription — so it is worth checking even when a charitable fund is closed, because it does not depend on fund balances.
Ofev sits on a Part D specialty tier, which is where Extra Help makes the largest difference: with full Extra Help a covered brand-name drug costs about $12.65 in 2026 instead of specialty-tier coinsurance. Extra Help does not depend on a fund balance and does not conflict with a TotalAssist grant. Ask Boehringer Cares how it treats Extra Help before applying there, since some manufacturer programs require Medicare applicants to pursue it first — we could not confirm whether this one does.
In 2026, people with full Extra Help generally pay no more than $12.65 for a covered brand-name drug. Income must be below about $23,940 a year for one person ($32,460 for a couple) and countable resources under $18,090 ($36,100 for a couple). Apply free through Social Security — online, by phone at 1-800-772-1213, or in person — and never pay anyone to apply for you.
Extra Help explained (Utah) · Check if you might qualify · Medicare Savings Programs · All help paying for Medicare
Government program
Medicare Extra Help (Part D Low-Income Subsidy)
Medicare / Social Security Administration
Status: Year-round federal program (figures for 2026)
Not a grant for one drug — a Medicare program that lowers what qualifying beneficiaries pay for their Part D premium, deductible and every covered prescription.
If you have Medicare: For people with Medicare Part D or a Medicare Advantage drug plan who have limited income and resources.
What it can cover: Part D premium and deductible (often to $0) and reduced copays — generally no more than $12.65 for a covered brand-name drug in 2026 with full Extra Help.
Who may qualify
- Income below 150% of the federal poverty level — about $23,940 a year for one person or $32,460 for a married couple in 2026.
- Countable resources (savings, investments — not your home or car) limited to $18,090 for an individual or $36,100 for a married couple living together in 2026 (Medicare.gov figures, which include a burial-expense allowance).
- Automatic if you have Medicaid, Supplemental Security Income (SSI), or a Medicare Savings Program.
What the application asks for
- Social Security number and Medicare number
- Income (Social Security, pensions, wages) for you and a spouse you live with
- Value of savings, investments and other countable resources
How to apply
You (or someone helping you) apply free through Social Security — online, by phone, or at a Social Security office. There is never a fee to apply.
Key terms on this page
- Patient assistance program (PAP)
- A manufacturer program that provides its medication free or at low cost to people who meet income and insurance rules. Many PAPs accept Medicare Part D enrollees; each sets its own criteria.
- Copay card / savings card
- A manufacturer discount for commercially insured patients. Federal anti-kickback rules mean these cards generally cannot be used with Medicare, Medicaid or other government insurance.
- Charitable copay grant
- Money from a nonprofit foundation (for example HealthWell or Patient Advocate Foundation) that pays eligible copays or coinsurance for a specific diagnosis. A drug can be listed while the fund is closed to new applicants.
- Federal poverty level (FPL)
- A federal income measure that assistance programs use as a yardstick — "300% of FPL", "500% of FPL". The percentage is a rule, but the dollar figure behind it comes from a table each program publishes itself, built on a chosen year of the HHS poverty guidelines. Two programs can quote the same percentage in the same year and still list different dollar limits; compare each program against its own table, not against another program.
- Medicare Extra Help
- The Part D Low-Income Subsidy: a Medicare program that lowers or eliminates Part D premiums, deductibles and copays for beneficiaries with limited income and resources. You apply through Social Security.
- Maximum Fair Price (MFP)
- The price Medicare negotiated for a selected drug under the Medicare Drug Price Negotiation Program. It applies to Part D plans, not to the pharmacy cash price, and it lowers what plans and enrollees pay for that drug.
Related medication assistance guides
Frequently Asked Questions
Does Medicare cover Ofev?
Is there an Ofev patient assistance program for people on Medicare?
Is there a charitable grant for Ofev right now?
I have a lung disease — can I use a COPD assistance fund for Ofev?
Can I use the Ofev savings card with Medicare?
Is there a generic for Ofev?
What is Ofev's Medicare negotiated price?
Sources
- Ofev prescribing information (DailyMed) — U.S. National Library of Medicine (2026-08-26)
- DailyMed label search — nintedanib — U.S. National Library of Medicine (2026-08-26)
- TotalAssist — Pulmonary fibrosis (PF) fund — Patient Advocate Foundation (2026-08-26)
- TotalAssist — Chronic obstructive pulmonary disease (COPD) fund — Patient Advocate Foundation (2026-08-26)
- TotalAssist eligibility requirements — Patient Advocate Foundation (2026-08-26)
- Get notified when a fund opens — TotalAssist — Patient Advocate Foundation (2026-08-26)
- HealthWell Pulmonary Fibrosis fund — HealthWell Foundation (2026-08-26)
- HealthWell Systemic Sclerosis with Interstitial Lung Disease fund — HealthWell Foundation (2026-08-26)
- HealthWell disease funds (status list) — HealthWell Foundation (2026-08-26)
- Good Days — diseases covered — Good Days (2026-08-26)
- Boehringer Cares Patient Assistance Portal — Boehringer Ingelheim (2026-08-26)
- Boehringer Ingelheim Cares Foundation, Inc. — therapies offered — Partnership for Prescription Assistance (PhRMA) (2026-08-26)
- RxAssist — BI Cares Patient Assistance Program — RxAssist (Rhode Island Hospital / Brown University) (2026-08-26)
- Ofev savings card terms and conditions — Boehringer Ingelheim Pharmaceuticals (2026-08-26)
- Selected Drug List and Negotiated Prices (Maximum Fair Prices) data file — CMS (2026-08-26)
- MFP explanation for Ofev (initial price applicability year 2027) — CMS (2026-08-26)
- Negotiated prices for initial price applicability year 2027 (fact sheet) — CMS (2026-08-26)
- TrumpRx — browse all medicines — TrumpRx.gov (2026-08-26)
- Your Medicare in 2026: what you need to know — Medicare.gov (2026-08-26)
- Help with drug costs (Extra Help) — Medicare.gov (2026-08-26)
- Special Advisory Bulletin: Pharmaceutical Manufacturer Copayment Coupons — HHS Office of Inspector General (2026-08-26)
Having trouble figuring out your prescription costs?
If you live in Vernal or the Uintah Basin, Vernal Medicare can help you understand your Medicare prescription coverage and where to look for Ofev assistance — free, no pressure. We don't award grants or decide eligibility; the programs above do. We help you find and apply to the right ones.